Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)

Background. We evaluated a candidate A/Anhui/2013(H7N9) pandemic live attenuated influenza vaccine (pLAIV) in healthy adults, and assessed the ability of 1 or 2 doses to induce immune memory. Methods. Healthy subjects in 2 age groups (18–49 years and 50–70 years) with undetectable hemagglutination-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobhanie, Mahdee, Matsuoka, Yumiko, Jegaskanda, Sinthujan, Fitzgerald, Theresa, Mallory, Raburn, Chen, Zhongying, Luke, Catherine, Treanor, John, Subbarao, Kanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760421/
https://www.ncbi.nlm.nih.gov/pubmed/26655841
http://dx.doi.org/10.1093/infdis/jiv526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760421/
https://www.ncbi.nlm.nih.gov/pubmed/26655841
http://dx.doi.org/10.1093/infdis/jiv526

Ejemplares similares